We proposed that silodosin administration preoperatively may facilitate ureteral access sheath (UAS) placement prior to flexible ureteroscopy (F-URS) and decrease the incidence of ureteric injury in some difficult cases.
Urolithiasis is a common urological disorder in the world and has a significant effect on the global health system. The goal of treatment is to achieve the highest stone-free rate (SFR) with the least invasive. Per¬cutaneous nephrolithotomy and flexible ureterorenoscopy (F-URS) are the two main minimally invasive procedures for the treatment of upper urinary tract stones. The challenging step in flexible ureterorenoscopy (F-URS) is ureteroscopic access sheath (UAS) placement, which facilitates fast and safe access to the ureter and collecting system; improves visibility; reduces the risk of infection by reducing intrarenal pressure. However, in some cases, the acute ureteric injury may occur during ureteroscopic access sheath (UAS) placement.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
140
Patients in this group had flexible ureteroscopy (F-URS) with preoperative daily uptake of 8 mg silodosin for one week.
included 70 patients for whom flexible ureteroscopy (F-URS) was done with daily preoperative intake of placebo tablets.
Benha University Hospitals
Banhā, Benha, Egypt
Entrance to bladder time (ETBT)
Entrance to bladder time (ETBT) will be recorded
Time frame: Intraoperatively
Entrance to ureteric orifice time (ETUOT)
Entrance to ureteric orifice time (ETUOT) will be recorded
Time frame: Intraoperatively
Application of access sheath time (AAST)
Application of access sheath time (AAST) will be recorded
Time frame: Intraoperatively
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.